Table 1.
Summary of dogs’ characteristics and histories
| Pt. No. | Breed | Age (yrs)/Gender | Body weight (kg) | Duration of clin. signs (months) | Tumor location | Clinical stage | Cytology | Histology | Previous treatment | Response to previous treatment | No. of tumor nodules |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Toy poodle | 16/FS | 6 | 3 | back | I | MCT | N/A | no | 1 | |
| 2 | Boxer | 7/M | 42 | 4 | scapula | I | MCT | N/A | no | 1 | |
| 3 | Cross-breed | 10/FS | 16.5 | 12 | hind leg | II | MCT | N/A | no | 1 | |
| 4 | Boxer | 10/FS | 27 | 6 | perineum, back | II | MCT | grade II | no | 2 | |
| 5 | Boxer | 10/M | 35 | 2 | scrotum, scapula | III | MCT | grade II | no | 4 | |
| 6 | Bullterrier | 5/FS | 20 | >12 | hind leg | II | MCT | grade II | surgery 2x chemotherapy (vincristine, CCNU) | recurrence | 2 |
| 7 | Siberian husky | 11/FS | 18 | < 1 | fore leg | III | MCT | grade III | no | 1 | |
| 8 | French bull-dog | 7/M | 12 | 4 | multicentric | III | MCT | grade III | surgery chemotherapy (vincristine) | recurrence PD | >10 |
FS, spayed female; MCT, mast cell tumor; M, male; CCNU, lomustine; PD, progressive disease